Learn about Avalyn’s MIST Study and the upcoming phase 2b clinical data on its inhaled pirfenidone program (AP01), focusing on patients with progressive pulmonary fibrosis (PPF). Whether you are new [Read More]
Patients Helping Patients
Learn about Avalyn’s MIST Study and the upcoming phase 2b clinical data on its inhaled pirfenidone program (AP01), focusing on patients with progressive pulmonary fibrosis (PPF). Whether you are new [Read More]
